News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,667 Results
Type
Article (2462)
Company Profile (1)
Press Release (19204)
Section
Business (3978)
Career Advice (20)
Deals (646)
Drug Delivery (5)
Drug Development (5052)
Employer Resources (1)
FDA (903)
Job Trends (726)
News (10764)
Policy (1210)
Tag
Academia (98)
Accelerated approval (1)
Adcomms (2)
Allergies (4)
Alliances (1159)
ALS (4)
Alzheimer's disease (30)
Antibody-drug conjugate (ADC) (38)
Approvals (946)
Artificial intelligence (3)
Autoimmune disease (4)
Bankruptcy (4)
Best Places to Work (730)
Biosimilars (18)
Biotechnology (1)
Bladder cancer (16)
Brain cancer (2)
Breast cancer (243)
Cancer (542)
Cardiovascular disease (19)
Career advice (20)
CAR-T (14)
Cell therapy (17)
Cervical cancer (4)
Clinical research (4801)
Collaboration (66)
Compensation (20)
Complete response letters (2)
COVID-19 (33)
C-suite (7)
Data (440)
Depression (7)
Dermatology (5)
Diabetes (44)
Diagnostics (139)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (5)
Drug pricing (5)
Drug shortages (3)
Duchenne muscular dystrophy (2)
Earnings (1891)
Editorial (3)
Employer resources (1)
Events (2758)
Executive appointments (6)
FDA (1086)
Funding (36)
Gene editing (1)
Gene therapy (16)
GLP-1 (175)
Government (113)
Guidances (10)
Healthcare (453)
HIV (6)
Immunology and inflammation (6)
Indications (20)
Infectious disease (37)
Inflammatory bowel disease (2)
Intellectual property (8)
IPO (318)
Job creations (59)
Job search strategy (20)
Kidney cancer (2)
Layoffs (6)
Legal (136)
Liver cancer (5)
Longevity (2)
Lung cancer (46)
Lymphoma (6)
Manufacturing (16)
MASH (28)
Medical device (85)
Medtech (85)
Mergers & acquisitions (367)
Metabolic disorders (194)
mRNA (2)
NASH (7)
Neuropsychiatric disorders (6)
Neuroscience (51)
NextGen: Class of 2026 (184)
Non-profit (69)
Obesity (130)
Opinion (4)
Ovarian cancer (39)
Pain (9)
Parkinson's disease (2)
Patents (13)
Patient recruitment (27)
Peanut (1)
People (833)
Phase 1 (951)
Phase 2 (1858)
Phase 3 (2197)
Pipeline (330)
Policy (1)
Postmarket research (233)
Preclinical (377)
Prostate cancer (86)
Radiopharmaceuticals (12)
Rare diseases (44)
Real estate (79)
Regulatory (1238)
Reports (4)
Research institute (103)
RNA editing (1)
RSV (2)
Schizophrenia (5)
Series A (5)
Series B (7)
Sickle cell disease (6)
Spinal muscular atrophy (1)
Sponsored (3)
Startups (77)
Stomach cancer (1)
Supply chain (4)
Tariffs (1)
The Weekly (1)
Vaccines (10)
Weight loss (75)
Women's health (34)
Date
Last 7 days (25)
Last 30 days (84)
Last 365 days (1078)
2026 (264)
2025 (1084)
2024 (1189)
2023 (1270)
2022 (1853)
2021 (1703)
2020 (1543)
2019 (1255)
2018 (1000)
2017 (1040)
2016 (927)
2015 (1238)
2014 (805)
2013 (656)
2012 (716)
2011 (723)
2010 (716)
Location
Africa (17)
Arizona (2)
Arkansas (1)
Asia (1190)
Australia (208)
California (500)
Canada (79)
China (54)
Colorado (9)
Connecticut (10)
Delaware (47)
Europe (3015)
Florida (35)
Georgia (8)
Idaho (1)
Illinois (29)
India (3)
Indiana (55)
Iowa (3)
Japan (47)
Kentucky (1)
Louisiana (1)
Maryland (22)
Massachusetts (213)
Michigan (4)
Minnesota (9)
Missouri (1)
Nevada (3)
New Jersey (209)
New York (100)
North Carolina (24)
Northern California (267)
Ohio (5)
Oregon (1)
Pennsylvania (124)
Puerto Rico (2)
South America (32)
South Carolina (1)
Southern California (199)
Tennessee (1)
Texas (53)
United States (1444)
Utah (4)
Virginia (3)
Washington D.C. (1)
Washington State (7)
Wisconsin (1)
21,667 Results for "teikoku hormone mfg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
City of Hope Opens Clinical Trial to Protect Heart Health of Prostate Cancer Patients Receiving Hormone Therapy
January 27, 2026
·
3 min read
Press Releases
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
July 15, 2025
·
11 min read
Press Releases
MIUDELLA® Hormone-Free Copper Intrauterine System (IUS) Phase 3 Data Publication in Contraception Honored with Daniel Mishell, Jr. MD Outstanding Article Award at Society of Family Planning Annual Meeting
October 28, 2025
·
10 min read
Press Releases
Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism
September 8, 2025
·
7 min read
Press Releases
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
November 10, 2025
·
4 min read
Biotech Beach
YourChoice Therapeutics Completes Phase 1a Clinical Study for First Hormone-Free Male Birth Control Pill
YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, has completed its first-in-human clinical study for YCT-529, designed to be the first hormone-free birth control pill for men.
June 3, 2024
·
4 min read
Press Releases
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
July 11, 2025
·
19 min read
Press Releases
Astellas and Pfizer’s XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
May 23, 2025
·
20 min read
Press Releases
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
September 28, 2025
·
7 min read
Press Releases
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
June 2, 2025
·
9 min read
Previous
2 of 2,167
Next
